Sympathetic state evaluation for renal neuromodulation therapy
US11457972B2 · kind B2 · utility
0Cited by
2References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 9, 2019 |
| Grant date | Oct 4, 2022 |
| Priority date | — |
| Expiry date | Aug 2, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B2018/00613
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Methods for treating dyspnea with therapeutic renal neuromodulation and associated system and methods are disclosed herein. One aspect of the present technology, for example, is directed to methods that block, reduce, and/or inhibit renal sympathetic nerve activity to achieve a reduction in central sympathetic tone. Renal sympathetic nerve activity may be altered or modulated along the afferent and/or efferent pathway. The achieved reduction in central sympathetic tone may carry therapeutic benefits for patients with dyspnea.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.